Last updated on February 2009

Ciclophosphamide Vincristine Myocet and Prednisone With Rituximab in 1st-Line Treatment for Patients With No-Hodgkin B Lymphoma and Cardiovascular (CV) Risk


Brief description of study

The purpose of this study is to evaluate the efficacy (and safety) of the following treatment squeme:Ciclophosphamide, Vincristine, lyposomal Doxorrubicine (Myocet) and Prednisone,combined with Rituximab in first line treatment for patients with aggresive No Hodgkin B lymphoma and cardiovascular risk

Detailed Study Description

Phase II, multicenter, open , 1-arm study.

Clinical Study Identifier: NCT00849355

Contact Investigators or Research Sites near you

Start Over

Antonio Martinez

Hospital Santa M del Rosell
Murcia, Spain
1.58miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.